Condition
Bietti Crystalline Dystrophy
Total Trials
5
Recruiting
0
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Early P 1 (1)
P 1 (2)
P 3 (2)
Trial Status
Active Not Recruiting3
Unknown1
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06743646Phase 3Active Not Recruiting
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT07586306Phase 1Not Yet RecruitingPrimary
A Safety Study of Contralateral Eye Dosing of VGR-R01 in Participants With Bietti's Crystalline Dystrophy (BCD)
NCT06699108Phase 3Active Not RecruitingPrimary
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
NCT05694598Phase 1Active Not RecruitingPrimary
Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy
NCT05399069Early Phase 1UnknownPrimary
Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy
Showing all 5 trials